nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftizoxime—Neutropenia—Everolimus—kidney cancer	0.00547	0.00547	CcSEcCtD
Ceftizoxime—Lactic dehydrogenase activity increased—Doxorubicin—kidney cancer	0.0054	0.0054	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Sorafenib—kidney cancer	0.00529	0.00529	CcSEcCtD
Ceftizoxime—Neutropenia—Erlotinib—kidney cancer	0.00527	0.00527	CcSEcCtD
Ceftizoxime—Injection site pain—Capecitabine—kidney cancer	0.00526	0.00526	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Sunitinib—kidney cancer	0.00509	0.00509	CcSEcCtD
Ceftizoxime—Anaemia—Temsirolimus—kidney cancer	0.00506	0.00506	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Erlotinib—kidney cancer	0.00499	0.00499	CcSEcCtD
Ceftizoxime—Leukopenia—Temsirolimus—kidney cancer	0.0049	0.0049	CcSEcCtD
Ceftizoxime—Agranulocytosis—Vinblastine—kidney cancer	0.00488	0.00488	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Dactinomycin—kidney cancer	0.00482	0.00482	CcSEcCtD
Ceftizoxime—Anaemia—Pazopanib—kidney cancer	0.00477	0.00477	CcSEcCtD
Ceftizoxime—Blood lactate dehydrogenase increased—Doxorubicin—kidney cancer	0.00476	0.00476	CcSEcCtD
Ceftizoxime—Neutropenia—Sorafenib—kidney cancer	0.00475	0.00475	CcSEcCtD
Ceftizoxime—Convulsion—Temsirolimus—kidney cancer	0.00474	0.00474	CcSEcCtD
Ceftizoxime—Haemoglobin—Vinblastine—kidney cancer	0.00472	0.00472	CcSEcCtD
Ceftizoxime—Cellulitis—Capecitabine—kidney cancer	0.00472	0.00472	CcSEcCtD
Ceftizoxime—Haemoglobin—Everolimus—kidney cancer	0.0047	0.0047	CcSEcCtD
Ceftizoxime—Haemorrhage—Vinblastine—kidney cancer	0.0047	0.0047	CcSEcCtD
Ceftizoxime—Haemorrhage—Everolimus—kidney cancer	0.00468	0.00468	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Vinblastine—kidney cancer	0.00467	0.00467	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Everolimus—kidney cancer	0.00466	0.00466	CcSEcCtD
Ceftizoxime—Pancytopenia—Sunitinib—kidney cancer	0.00464	0.00464	CcSEcCtD
Ceftizoxime—Leukopenia—Pazopanib—kidney cancer	0.00462	0.00462	CcSEcCtD
Ceftizoxime—Neutropenia—Sunitinib—kidney cancer	0.00457	0.00457	CcSEcCtD
Ceftizoxime—Haemoglobin—Erlotinib—kidney cancer	0.00454	0.00454	CcSEcCtD
Ceftizoxime—Haemorrhage—Erlotinib—kidney cancer	0.00451	0.00451	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Sorafenib—kidney cancer	0.00449	0.00449	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Temsirolimus—kidney cancer	0.00447	0.00447	CcSEcCtD
Ceftizoxime—Thrombocytosis—Doxorubicin—kidney cancer	0.00445	0.00445	CcSEcCtD
Ceftizoxime—Phlebitis—Paclitaxel—kidney cancer	0.00441	0.00441	CcSEcCtD
Ceftizoxime—Pancytopenia—Dactinomycin—kidney cancer	0.00439	0.00439	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Temsirolimus—kidney cancer	0.00438	0.00438	CcSEcCtD
Ceftizoxime—Neutropenia—Dactinomycin—kidney cancer	0.00432	0.00432	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Sunitinib—kidney cancer	0.00432	0.00432	CcSEcCtD
Ceftizoxime—Erythema multiforme—Erlotinib—kidney cancer	0.00427	0.00427	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Pazopanib—kidney cancer	0.00412	0.00412	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Dactinomycin—kidney cancer	0.00409	0.00409	CcSEcCtD
Ceftizoxime—Haemoglobin—Sorafenib—kidney cancer	0.00408	0.00408	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Gemcitabine—kidney cancer	0.00408	0.00408	CcSEcCtD
Ceftizoxime—Haemorrhage—Sorafenib—kidney cancer	0.00406	0.00406	CcSEcCtD
Ceftizoxime—Haemoglobin—Sunitinib—kidney cancer	0.00393	0.00393	CcSEcCtD
Ceftizoxime—Pancytopenia—Vincristine—kidney cancer	0.00392	0.00392	CcSEcCtD
Ceftizoxime—Haemorrhage—Sunitinib—kidney cancer	0.00391	0.00391	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Sunitinib—kidney cancer	0.00389	0.00389	CcSEcCtD
Ceftizoxime—Neutropenia—Vincristine—kidney cancer	0.00386	0.00386	CcSEcCtD
Ceftizoxime—Agranulocytosis—Dactinomycin—kidney cancer	0.00385	0.00385	CcSEcCtD
Ceftizoxime—Erythema multiforme—Sorafenib—kidney cancer	0.00384	0.00384	CcSEcCtD
Ceftizoxime—Pain—Temsirolimus—kidney cancer	0.00382	0.00382	CcSEcCtD
Ceftizoxime—Paraesthesia—Pazopanib—kidney cancer	0.00378	0.00378	CcSEcCtD
Ceftizoxime—Anaemia—Vinblastine—kidney cancer	0.00378	0.00378	CcSEcCtD
Ceftizoxime—Anaemia—Everolimus—kidney cancer	0.00376	0.00376	CcSEcCtD
Ceftizoxime—Pancytopenia—Gemcitabine—kidney cancer	0.00372	0.00372	CcSEcCtD
Ceftizoxime—Erythema multiforme—Sunitinib—kidney cancer	0.0037	0.0037	CcSEcCtD
Ceftizoxime—Neutropenia—Gemcitabine—kidney cancer	0.00366	0.00366	CcSEcCtD
Ceftizoxime—Leukopenia—Vinblastine—kidney cancer	0.00366	0.00366	CcSEcCtD
Ceftizoxime—Leukopenia—Everolimus—kidney cancer	0.00365	0.00365	CcSEcCtD
Ceftizoxime—Phlebitis—Capecitabine—kidney cancer	0.00362	0.00362	CcSEcCtD
Ceftizoxime—Pain—Pazopanib—kidney cancer	0.0036	0.0036	CcSEcCtD
Ceftizoxime—Convulsion—Vinblastine—kidney cancer	0.00354	0.00354	CcSEcCtD
Ceftizoxime—Body temperature increased—Temsirolimus—kidney cancer	0.00353	0.00353	CcSEcCtD
Ceftizoxime—Convulsion—Everolimus—kidney cancer	0.00353	0.00353	CcSEcCtD
Ceftizoxime—Erythema multiforme—Dactinomycin—kidney cancer	0.0035	0.0035	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Gemcitabine—kidney cancer	0.00346	0.00346	CcSEcCtD
Ceftizoxime—Haemolytic anaemia—Capecitabine—kidney cancer	0.00345	0.00345	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Paclitaxel—kidney cancer	0.00342	0.00342	CcSEcCtD
Ceftizoxime—Injection site pain—Doxorubicin—kidney cancer	0.00339	0.00339	CcSEcCtD
Ceftizoxime—Hypersensitivity—Temsirolimus—kidney cancer	0.00329	0.00329	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Vincristine—kidney cancer	0.00329	0.00329	CcSEcCtD
Ceftizoxime—Anaemia—Sorafenib—kidney cancer	0.00327	0.00327	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Vinblastine—kidney cancer	0.00327	0.00327	CcSEcCtD
Ceftizoxime—Agranulocytosis—Gemcitabine—kidney cancer	0.00326	0.00326	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Everolimus—kidney cancer	0.00325	0.00325	CcSEcCtD
Ceftizoxime—Leukopenia—Sorafenib—kidney cancer	0.00316	0.00316	CcSEcCtD
Ceftizoxime—Pruritus—Temsirolimus—kidney cancer	0.00316	0.00316	CcSEcCtD
Ceftizoxime—Haemoglobin—Gemcitabine—kidney cancer	0.00315	0.00315	CcSEcCtD
Ceftizoxime—Anaemia—Sunitinib—kidney cancer	0.00314	0.00314	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Erlotinib—kidney cancer	0.00314	0.00314	CcSEcCtD
Ceftizoxime—Haemorrhage—Gemcitabine—kidney cancer	0.00314	0.00314	CcSEcCtD
Ceftizoxime—Pancytopenia—Paclitaxel—kidney cancer	0.00312	0.00312	CcSEcCtD
Ceftizoxime—Neutropenia—Paclitaxel—kidney cancer	0.00307	0.00307	CcSEcCtD
Ceftizoxime—Diarrhoea—Temsirolimus—kidney cancer	0.00306	0.00306	CcSEcCtD
Ceftizoxime—Leukopenia—Sunitinib—kidney cancer	0.00305	0.00305	CcSEcCtD
Ceftizoxime—Cellulitis—Doxorubicin—kidney cancer	0.00304	0.00304	CcSEcCtD
Ceftizoxime—Paraesthesia—Vinblastine—kidney cancer	0.003	0.003	CcSEcCtD
Ceftizoxime—Paraesthesia—Everolimus—kidney cancer	0.00299	0.00299	CcSEcCtD
Ceftizoxime—Pruritus—Pazopanib—kidney cancer	0.00298	0.00298	CcSEcCtD
Ceftizoxime—Anaemia—Dactinomycin—kidney cancer	0.00298	0.00298	CcSEcCtD
Ceftizoxime—Erythema multiforme—Gemcitabine—kidney cancer	0.00297	0.00297	CcSEcCtD
Ceftizoxime—Convulsion—Sunitinib—kidney cancer	0.00295	0.00295	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.0029	0.0029	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Sorafenib—kidney cancer	0.00289	0.00289	CcSEcCtD
Ceftizoxime—Leukopenia—Dactinomycin—kidney cancer	0.00288	0.00288	CcSEcCtD
Ceftizoxime—Diarrhoea—Pazopanib—kidney cancer	0.00288	0.00288	CcSEcCtD
Ceftizoxime—Pain—Vinblastine—kidney cancer	0.00285	0.00285	CcSEcCtD
Ceftizoxime—Pain—Everolimus—kidney cancer	0.00284	0.00284	CcSEcCtD
Ceftizoxime—Vomiting—Temsirolimus—kidney cancer	0.00284	0.00284	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Sorafenib—kidney cancer	0.00283	0.00283	CcSEcCtD
Ceftizoxime—Rash—Temsirolimus—kidney cancer	0.00282	0.00282	CcSEcCtD
Ceftizoxime—Dermatitis—Temsirolimus—kidney cancer	0.00282	0.00282	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Capecitabine—kidney cancer	0.0028	0.0028	CcSEcCtD
Ceftizoxime—Vaginal inflammation—Doxorubicin—kidney cancer	0.00277	0.00277	CcSEcCtD
Ceftizoxime—Pain—Erlotinib—kidney cancer	0.00274	0.00274	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Sunitinib—kidney cancer	0.00272	0.00272	CcSEcCtD
Ceftizoxime—Vomiting—Pazopanib—kidney cancer	0.00268	0.00268	CcSEcCtD
Ceftizoxime—Anaemia—Vincristine—kidney cancer	0.00266	0.00266	CcSEcCtD
Ceftizoxime—Rash—Pazopanib—kidney cancer	0.00265	0.00265	CcSEcCtD
Ceftizoxime—Nausea—Temsirolimus—kidney cancer	0.00265	0.00265	CcSEcCtD
Ceftizoxime—Dermatitis—Pazopanib—kidney cancer	0.00265	0.00265	CcSEcCtD
Ceftizoxime—Haemoglobin—Paclitaxel—kidney cancer	0.00264	0.00264	CcSEcCtD
Ceftizoxime—Body temperature increased—Everolimus—kidney cancer	0.00263	0.00263	CcSEcCtD
Ceftizoxime—Haemorrhage—Paclitaxel—kidney cancer	0.00263	0.00263	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Paclitaxel—kidney cancer	0.00261	0.00261	CcSEcCtD
Ceftizoxime—Vaginal infection—Doxorubicin—kidney cancer	0.00261	0.00261	CcSEcCtD
Ceftizoxime—Aplastic anaemia—Doxorubicin—kidney cancer	0.0026	0.0026	CcSEcCtD
Ceftizoxime—Leukopenia—Vincristine—kidney cancer	0.00258	0.00258	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Dactinomycin—kidney cancer	0.00257	0.00257	CcSEcCtD
Ceftizoxime—Pancytopenia—Capecitabine—kidney cancer	0.00256	0.00256	CcSEcCtD
Ceftizoxime—Body temperature increased—Erlotinib—kidney cancer	0.00254	0.00254	CcSEcCtD
Ceftizoxime—Anaemia—Gemcitabine—kidney cancer	0.00252	0.00252	CcSEcCtD
Ceftizoxime—Neutropenia—Capecitabine—kidney cancer	0.00252	0.00252	CcSEcCtD
Ceftizoxime—Nausea—Pazopanib—kidney cancer	0.0025	0.0025	CcSEcCtD
Ceftizoxime—Paraesthesia—Sunitinib—kidney cancer	0.00249	0.00249	CcSEcCtD
Ceftizoxime—Convulsion—Vincristine—kidney cancer	0.00249	0.00249	CcSEcCtD
Ceftizoxime—Erythema multiforme—Paclitaxel—kidney cancer	0.00248	0.00248	CcSEcCtD
Ceftizoxime—Pain—Sorafenib—kidney cancer	0.00247	0.00247	CcSEcCtD
Ceftizoxime—Hypersensitivity—Vinblastine—kidney cancer	0.00246	0.00246	CcSEcCtD
Ceftizoxime—Hypersensitivity—Everolimus—kidney cancer	0.00245	0.00245	CcSEcCtD
Ceftizoxime—Leukopenia—Gemcitabine—kidney cancer	0.00244	0.00244	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.00238	0.00238	CcSEcCtD
Ceftizoxime—Pain—Sunitinib—kidney cancer	0.00237	0.00237	CcSEcCtD
Ceftizoxime—Pruritus—Everolimus—kidney cancer	0.00235	0.00235	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Vincristine—kidney cancer	0.00235	0.00235	CcSEcCtD
Ceftizoxime—Phlebitis—Doxorubicin—kidney cancer	0.00233	0.00233	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Vincristine—kidney cancer	0.0023	0.0023	CcSEcCtD
Ceftizoxime—Diarrhoea—Vinblastine—kidney cancer	0.00228	0.00228	CcSEcCtD
Ceftizoxime—Body temperature increased—Sorafenib—kidney cancer	0.00228	0.00228	CcSEcCtD
Ceftizoxime—Diarrhoea—Everolimus—kidney cancer	0.00227	0.00227	CcSEcCtD
Ceftizoxime—Pruritus—Erlotinib—kidney cancer	0.00227	0.00227	CcSEcCtD
Ceftizoxime—Pain—Dactinomycin—kidney cancer	0.00225	0.00225	CcSEcCtD
Ceftizoxime—Agranulocytosis—Capecitabine—kidney cancer	0.00224	0.00224	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Gemcitabine—kidney cancer	0.00223	0.00223	CcSEcCtD
Ceftizoxime—Body temperature increased—Sunitinib—kidney cancer	0.0022	0.0022	CcSEcCtD
Ceftizoxime—Diarrhoea—Erlotinib—kidney cancer	0.00219	0.00219	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Gemcitabine—kidney cancer	0.00218	0.00218	CcSEcCtD
Ceftizoxime—Haemoglobin—Capecitabine—kidney cancer	0.00217	0.00217	CcSEcCtD
Ceftizoxime—Haemorrhage—Capecitabine—kidney cancer	0.00215	0.00215	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Capecitabine—kidney cancer	0.00214	0.00214	CcSEcCtD
Ceftizoxime—Hypersensitivity—Sorafenib—kidney cancer	0.00213	0.00213	CcSEcCtD
Ceftizoxime—Vomiting—Vinblastine—kidney cancer	0.00212	0.00212	CcSEcCtD
Ceftizoxime—Vomiting—Everolimus—kidney cancer	0.00211	0.00211	CcSEcCtD
Ceftizoxime—Anaemia—Paclitaxel—kidney cancer	0.00211	0.00211	CcSEcCtD
Ceftizoxime—Paraesthesia—Vincristine—kidney cancer	0.00211	0.00211	CcSEcCtD
Ceftizoxime—Rash—Everolimus—kidney cancer	0.0021	0.0021	CcSEcCtD
Ceftizoxime—Dermatitis—Everolimus—kidney cancer	0.00209	0.00209	CcSEcCtD
Ceftizoxime—Body temperature increased—Dactinomycin—kidney cancer	0.00208	0.00208	CcSEcCtD
Ceftizoxime—Leukopenia—Paclitaxel—kidney cancer	0.00205	0.00205	CcSEcCtD
Ceftizoxime—Hypersensitivity—Sunitinib—kidney cancer	0.00205	0.00205	CcSEcCtD
Ceftizoxime—Pruritus—Sorafenib—kidney cancer	0.00204	0.00204	CcSEcCtD
Ceftizoxime—Vomiting—Erlotinib—kidney cancer	0.00204	0.00204	CcSEcCtD
Ceftizoxime—Erythema multiforme—Capecitabine—kidney cancer	0.00204	0.00204	CcSEcCtD
Ceftizoxime—Rash—Erlotinib—kidney cancer	0.00202	0.00202	CcSEcCtD
Ceftizoxime—Dermatitis—Erlotinib—kidney cancer	0.00202	0.00202	CcSEcCtD
Ceftizoxime—Pain—Vincristine—kidney cancer	0.00201	0.00201	CcSEcCtD
Ceftizoxime—Paraesthesia—Gemcitabine—kidney cancer	0.002	0.002	CcSEcCtD
Ceftizoxime—Nausea—Vinblastine—kidney cancer	0.00198	0.00198	CcSEcCtD
Ceftizoxime—Convulsion—Paclitaxel—kidney cancer	0.00198	0.00198	CcSEcCtD
Ceftizoxime—Nausea—Everolimus—kidney cancer	0.00197	0.00197	CcSEcCtD
Ceftizoxime—Diarrhoea—Sorafenib—kidney cancer	0.00197	0.00197	CcSEcCtD
Ceftizoxime—Pruritus—Sunitinib—kidney cancer	0.00196	0.00196	CcSEcCtD
Ceftizoxime—Hypersensitivity—Dactinomycin—kidney cancer	0.00194	0.00194	CcSEcCtD
Ceftizoxime—Pain—Gemcitabine—kidney cancer	0.00191	0.00191	CcSEcCtD
Ceftizoxime—Nausea—Erlotinib—kidney cancer	0.00191	0.00191	CcSEcCtD
Ceftizoxime—Diarrhoea—Sunitinib—kidney cancer	0.0019	0.0019	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Paclitaxel—kidney cancer	0.00187	0.00187	CcSEcCtD
Ceftizoxime—Body temperature increased—Vincristine—kidney cancer	0.00186	0.00186	CcSEcCtD
Ceftizoxime—Vomiting—Sorafenib—kidney cancer	0.00183	0.00183	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Paclitaxel—kidney cancer	0.00183	0.00183	CcSEcCtD
Ceftizoxime—Rash—Sorafenib—kidney cancer	0.00182	0.00182	CcSEcCtD
Ceftizoxime—Dermatitis—Sorafenib—kidney cancer	0.00182	0.00182	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.00181	0.00181	CcSEcCtD
Ceftizoxime—Diarrhoea—Dactinomycin—kidney cancer	0.0018	0.0018	CcSEcCtD
Ceftizoxime—Vomiting—Sunitinib—kidney cancer	0.00177	0.00177	CcSEcCtD
Ceftizoxime—Body temperature increased—Gemcitabine—kidney cancer	0.00176	0.00176	CcSEcCtD
Ceftizoxime—Rash—Sunitinib—kidney cancer	0.00175	0.00175	CcSEcCtD
Ceftizoxime—Dermatitis—Sunitinib—kidney cancer	0.00175	0.00175	CcSEcCtD
Ceftizoxime—Anaemia—Capecitabine—kidney cancer	0.00173	0.00173	CcSEcCtD
Ceftizoxime—Hypersensitivity—Vincristine—kidney cancer	0.00173	0.00173	CcSEcCtD
Ceftizoxime—Eosinophilia—Doxorubicin—kidney cancer	0.00172	0.00172	CcSEcCtD
Ceftizoxime—Nausea—Sorafenib—kidney cancer	0.00171	0.00171	CcSEcCtD
Ceftizoxime—Leukopenia—Capecitabine—kidney cancer	0.00168	0.00168	CcSEcCtD
Ceftizoxime—Paraesthesia—Paclitaxel—kidney cancer	0.00168	0.00168	CcSEcCtD
Ceftizoxime—Vomiting—Dactinomycin—kidney cancer	0.00167	0.00167	CcSEcCtD
Ceftizoxime—Rash—Dactinomycin—kidney cancer	0.00166	0.00166	CcSEcCtD
Ceftizoxime—Nausea—Sunitinib—kidney cancer	0.00165	0.00165	CcSEcCtD
Ceftizoxime—Pancytopenia—Doxorubicin—kidney cancer	0.00165	0.00165	CcSEcCtD
Ceftizoxime—Neutropenia—Doxorubicin—kidney cancer	0.00162	0.00162	CcSEcCtD
Ceftizoxime—Diarrhoea—Vincristine—kidney cancer	0.00161	0.00161	CcSEcCtD
Ceftizoxime—Pain—Paclitaxel—kidney cancer	0.0016	0.0016	CcSEcCtD
Ceftizoxime—Pruritus—Gemcitabine—kidney cancer	0.00158	0.00158	CcSEcCtD
Ceftizoxime—Nausea—Dactinomycin—kidney cancer	0.00156	0.00156	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.00153	0.00153	CcSEcCtD
Ceftizoxime—Diarrhoea—Gemcitabine—kidney cancer	0.00152	0.00152	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Capecitabine—kidney cancer	0.0015	0.0015	CcSEcCtD
Ceftizoxime—Vomiting—Vincristine—kidney cancer	0.00149	0.00149	CcSEcCtD
Ceftizoxime—Rash—Vincristine—kidney cancer	0.00148	0.00148	CcSEcCtD
Ceftizoxime—Dermatitis—Vincristine—kidney cancer	0.00148	0.00148	CcSEcCtD
Ceftizoxime—Body temperature increased—Paclitaxel—kidney cancer	0.00147	0.00147	CcSEcCtD
Ceftizoxime—Agranulocytosis—Doxorubicin—kidney cancer	0.00144	0.00144	CcSEcCtD
Ceftizoxime—Vomiting—Gemcitabine—kidney cancer	0.00142	0.00142	CcSEcCtD
Ceftizoxime—Rash—Gemcitabine—kidney cancer	0.0014	0.0014	CcSEcCtD
Ceftizoxime—Dermatitis—Gemcitabine—kidney cancer	0.0014	0.0014	CcSEcCtD
Ceftizoxime—Haemoglobin—Doxorubicin—kidney cancer	0.0014	0.0014	CcSEcCtD
Ceftizoxime—Nausea—Vincristine—kidney cancer	0.0014	0.0014	CcSEcCtD
Ceftizoxime—Haemorrhage—Doxorubicin—kidney cancer	0.00139	0.00139	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Doxorubicin—kidney cancer	0.00138	0.00138	CcSEcCtD
Ceftizoxime—Paraesthesia—Capecitabine—kidney cancer	0.00137	0.00137	CcSEcCtD
Ceftizoxime—Hypersensitivity—Paclitaxel—kidney cancer	0.00137	0.00137	CcSEcCtD
Ceftizoxime—Nausea—Gemcitabine—kidney cancer	0.00132	0.00132	CcSEcCtD
Ceftizoxime—Pruritus—Paclitaxel—kidney cancer	0.00132	0.00132	CcSEcCtD
Ceftizoxime—Erythema multiforme—Doxorubicin—kidney cancer	0.00131	0.00131	CcSEcCtD
Ceftizoxime—Pain—Capecitabine—kidney cancer	0.00131	0.00131	CcSEcCtD
Ceftizoxime—Diarrhoea—Paclitaxel—kidney cancer	0.00128	0.00128	CcSEcCtD
Ceftizoxime—Body temperature increased—Capecitabine—kidney cancer	0.00121	0.00121	CcSEcCtD
Ceftizoxime—Vomiting—Paclitaxel—kidney cancer	0.00119	0.00119	CcSEcCtD
Ceftizoxime—Rash—Paclitaxel—kidney cancer	0.00118	0.00118	CcSEcCtD
Ceftizoxime—Dermatitis—Paclitaxel—kidney cancer	0.00118	0.00118	CcSEcCtD
Ceftizoxime—Hypersensitivity—Capecitabine—kidney cancer	0.00113	0.00113	CcSEcCtD
Ceftizoxime—Anaemia—Doxorubicin—kidney cancer	0.00112	0.00112	CcSEcCtD
Ceftizoxime—Nausea—Paclitaxel—kidney cancer	0.00111	0.00111	CcSEcCtD
Ceftizoxime—Pruritus—Capecitabine—kidney cancer	0.00108	0.00108	CcSEcCtD
Ceftizoxime—Leukopenia—Doxorubicin—kidney cancer	0.00108	0.00108	CcSEcCtD
Ceftizoxime—Convulsion—Doxorubicin—kidney cancer	0.00105	0.00105	CcSEcCtD
Ceftizoxime—Diarrhoea—Capecitabine—kidney cancer	0.00105	0.00105	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Doxorubicin—kidney cancer	0.000987	0.000987	CcSEcCtD
Ceftizoxime—Vomiting—Capecitabine—kidney cancer	0.000973	0.000973	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Doxorubicin—kidney cancer	0.000966	0.000966	CcSEcCtD
Ceftizoxime—Rash—Capecitabine—kidney cancer	0.000965	0.000965	CcSEcCtD
Ceftizoxime—Dermatitis—Capecitabine—kidney cancer	0.000964	0.000964	CcSEcCtD
Ceftizoxime—Nausea—Capecitabine—kidney cancer	0.000909	0.000909	CcSEcCtD
Ceftizoxime—Paraesthesia—Doxorubicin—kidney cancer	0.000886	0.000886	CcSEcCtD
Ceftizoxime—Pain—Doxorubicin—kidney cancer	0.000844	0.000844	CcSEcCtD
Ceftizoxime—Body temperature increased—Doxorubicin—kidney cancer	0.00078	0.00078	CcSEcCtD
Ceftizoxime—Hypersensitivity—Doxorubicin—kidney cancer	0.000727	0.000727	CcSEcCtD
Ceftizoxime—Pruritus—Doxorubicin—kidney cancer	0.000698	0.000698	CcSEcCtD
Ceftizoxime—Diarrhoea—Doxorubicin—kidney cancer	0.000675	0.000675	CcSEcCtD
Ceftizoxime—Vomiting—Doxorubicin—kidney cancer	0.000627	0.000627	CcSEcCtD
Ceftizoxime—Rash—Doxorubicin—kidney cancer	0.000622	0.000622	CcSEcCtD
Ceftizoxime—Dermatitis—Doxorubicin—kidney cancer	0.000622	0.000622	CcSEcCtD
Ceftizoxime—Nausea—Doxorubicin—kidney cancer	0.000586	0.000586	CcSEcCtD
